Exercise Intervention for Breast

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Breast+20 More
Exercise Intervention - Other
Eligibility
65+
Female
What conditions do you have?
Select

Study Summary

This trial is testing if it's feasible for older women with breast cancer to exercise during chemotherapy. Researchers hope this will help reduce the chemotherapy-toxicity risk.

Eligible Conditions
  • Breast
  • Anatomic Stage III Breast Cancer AJCC v8

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 6 Secondary · Reporting Duration: Baseline up to 1 month after chemotherapy

Month 1
Geriatric assessment
Outcome Expectations for Exercise (OEE) Scale Questionnaires
Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM) questionnaires
Quality of life questionnaires
Short Physical Performance Battery (SPPB)
Month 1
Adherence
Compliance
Incidence of adverse events (AEs)
Retention

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Supportive care (coaching, exercise, questionnaire)
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Exercise Intervention · No Placebo Group · N/A

Supportive care (coaching, exercise, questionnaire)Experimental Group · 6 Interventions: Discussion, Exercise Intervention, Medical Device Usage and Evaluation, Questionnaire Administration, Quality-of-Life Assessment, Informational Intervention · Intervention Types: Procedure, Other, Other, Other, Other, Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2018
N/A
~90

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline up to 1 month after chemotherapy

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,779 Previous Clinical Trials
1,784,741 Total Patients Enrolled
1 Trials studying Breast
40 Patients Enrolled for Breast
Meghan KaruturiPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
152 Total Patients Enrolled

Eligibility Criteria

Age 65+ · Female Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are female and aged 65 years or older.
You have had one or more breast cancers.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 10th, 2021

Last Reviewed: October 21st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.